日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

西罗莫司和自噬抑制剂治疗淋巴管肌瘤病:I期临床试验结果

El-Chemaly Souheil, Taveira-Dasilva Angelo, Goldberg Hilary J, Peters Elizabeth, Haughey Mary, Bienfang Don, Jones Amanda M, Julien-Williams Patricia, Cui Ye, Villalba Julian A, Bagwe Shefali, Maurer Rie, Rosas Ivan O, Moss Joel, Henske Elizabeth P

Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer

结节性硬化症复合体2型杂合性缺失与肺部疾病和癌症患者相关

Zhang, Li; Pacheco-Rodriguez, Gustavo; Steagall, Wendy K; Kato, Jiro; Haughey, Mary; Fontana, Joseph R; Manganiello, Vincent C; Moss, Joel

Natural history of pulmonary fibrosis in two subjects with the same telomerase mutation

两名携带相同端粒酶突变的受试者肺纤维化的自然病程

El-Chemaly, Souheil; Ziegler, Shira G; Calado, Rodrigo T; Wilson, Kirkland A; Wu, Hai Ping; Haughey, Mary; Peterson, Nathan R; Young, Neal S; Gahl, William A; Moss, Joel; Gochuico, Bernadette R

Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis

淋巴管肌瘤病患者中TSC2杂合性缺失的播散细胞的表型特征

Cai, Xiong; Pacheco-Rodriguez, Gustavo; Fan, Qing-Yuan; Haughey, Mary; Samsel, Leigh; El-Chemaly, Souheil; Wu, Hai-Ping; McCoy, J Philip; Steagall, Wendy K; Lin, Jing-Ping; Darling, Thomas N; Moss, Joel